Cencora, Inc.
Cencora, Inc.
Your view on COR
Overview
What the company does, where it operates, and who runs it.
About Cencora, Inc.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Robert P. Mauch PharmD
- Headquarters
- 1 West First Avenue, Conshohocken, PA, US
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Robert P. Mauch PharmD
- Headquarters
- 1 West First Avenue, Conshohocken, PA, US
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets.
In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.
The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe.
This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Cencora, Inc. from FRC's valuation model, read against the market price. COR last traded at $356.94, 19.9× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Cencora, Inc.. Starting points for Cencora, Inc.: P/E 19.9, EPS $18.26, beta 0.58 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Cencora, Inc.. Cencora, Inc. paid $2.46 per share over the last year — a 0.7% yield at the current $356.94 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Cencora, Inc.. Trailing twelve-month EPS for Cencora, Inc. stands at $18.26. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$371.60
average of 10 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy11
- Hold2
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Sep 2027 | Next YearFY Sep 2028 |
|---|---|---|---|---|
| Avg. estimate | $4.57 | $5.28 | $19.69 | $21.70 |
| Low estimate | $4.38 | $5.20 | $19.51 | $21.26 |
| High estimate | $4.69 | $5.32 | $19.88 | $22.12 |
| No. of analysts | 5 | 5 | 6 | 6 |
| Year-ago EPS | $4.08 | $4.75 | $17.95 | — |
| Growth | +12.0% | +11.2% | +9.7% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Sep 2027 | Next YearFY Sep 2028 |
|---|---|---|---|---|
| Avg. estimate | $90.44B | $82.15B | $352.39B | $368.42B |
| Low estimate | $90.11B | $81.90B | $351.48B | $363.64B |
| High estimate | $90.91B | $82.55B | $354.03B | $372.12B |
| No. of analysts | 4 | 4 | 7 | 6 |
| Year-ago revenue | $85.93B | $78.36B | $337.40B | — |
| Growth | +5.2% | +4.8% | +4.4% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, Investing; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Cencora, Inc.. Cencora, Inc. has reported as a listed company since 1995. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- CAHCardinal Health, Inc.Medical - Distribution$65.6B
- HSICHenry Schein, Inc.Medical - Distribution$9.4B
- MCKMcKesson CorporationMedical - Distribution$127.6B
- SHPMYShanghai Pharmaceuticals Holding Co., LtdMedical - Distribution$5.2B
- SHTDYSinopharm Group Co. Ltd.Medical - Distribution$8.8B
- SIG.AXSigma Healthcare LimitedMedical - Distribution
- YI111, Inc.Medical - Distribution$24M
More Medical - Distribution companies
- SZUKFSuzuken Co., Ltd.OTC$1.7B
- ZHYBFZhong Yuan Bio-Technology Holdings LimitedOTC$36M
- ZRSEFDocMorris AGOTC$497M
- AHGAkso Health GroupNASDAQ$1.1B
- AIXNAiXin Life International, Inc.OTC$4M
- ALFRYAlfresa Holdings CorporationOTC$3.0B
- AMFPFAmplifon S.p.A.OTC$3.5B
- ARHCFAlfresa Holdings CorporationOTC$2.2B
- ARRJFArjo AB (publ)OTC$840M
- BIMIBIMI International Medical Inc.OTC$1,156
ETFs holding Cencora, Inc.
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.10%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.08%
- VOVanguard Mid-Cap ETF$103.4B in assets0.57%
- IVViShares Core SP 500 ETF$852.9B in assets0.11%
- PPHVanEck Pharmaceutical ETF$1.1B in assets4.47%
- ZLU.TOBMO Low Volatility US Equity ETF$2.6B in assets3.05%
- IYKiShares US Consumer Staples ETF$1.5B in assets2.75%
Largest holders first, then the funds most concentrated in COR.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Cencora, Inc., and how their positions are changing. At a $68.11B market value, institutional positions materially move Cencora, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Cencora, Inc. executives and directors. Shares of Cencora, Inc. have traded between $223.92 and $369.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Cencora, Inc.. Cencora, Inc. is a $68.11B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Cencora, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Cencora, Inc.. Coverage tracks Cencora, Inc. within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Cencora, Inc.